// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Rheumatoid vasculitis presenting in the absence of rheumatoid arthritis

David A J Cromie - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Rheumatoid arthritis

N/A

A complex case of giant cell arteritis presenting with visual loss, tongue and scalp infarction and multiple cranial neuropathies

Judith Jade - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

Hypertrophic pulmonary osteoarthropathy, rheumatoid arthritis mimic: don’t distract with immunology

Abdul B Awan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Inflammatory Arthritis

Hydroxychloroquine

Seronegative arthritis in the context of CHIP: is this a new entity that needs further investigation?

Sarah Mohamed - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Seronegative arthritis

Hydroxychloroquine

Erdheim-Chester disease: a rare multisystem disorder

Gordon Starritt - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Erdheim-Chester disease

N/A

Rheumatologists beware! Digital ischaemia as a presenting feature in metastatic ovarian cancer

Jonathan H Miller - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Raynaud syndrome

N/A

A rare case of diffuse osteosclerosis

Sarah Mohamed - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Premature ovarian failure

Alkaline phosphatase

Deficiency of Adenosine Deaminase 2: a rare diagnosis in a case of suspected vasculitis

Mikalena Xenophontos - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Adenosine deaminase 2 deficiency

Adenosine

The evolution of neurosarcoidosis on infliximab: a case report

Hirushi S Jayasekera - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory Arthritis

Methotrexate

Rheumatology trainees’ experience of osteoporosis and metabolic bone disease: a UK-wide survey

Sarah A Hardcastle - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

An evaluation of the causes and outcomes of haemophagocytic lymphohistiocytosis in Sheffield Teaching Hospitals: 2016 to 2021

Bethany Awdas - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hemophagocytic lymphohistiocytosis

Anakinra

Arthritis in East Africa: an observational study

Catherine Kuo - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

A common measure of the impact of glucocorticoids in patients with inflammatory and autoimmune conditions - the Steroid PRO: A cross-cultural validation study with Rasch models

Susan Bridgewater - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Glucocorticoid

Association between ethnicity and initial response to TNF inhibitors in people with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA)

Man Fung Tsoi - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Clinicians’ levels of experience and roles influence the decisions made in telephone clinic consultations in rheumatology

Adlan Wafi Ramli - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Newcastle Giant Cell Arteritis (GCA) Fast Track Clinic: a clinical service evaluation

Chung M Lin - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

Glucocorticoid

Work resources for people with rheumatic and MSK conditions

Nandini Mishra - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Telephone clinic consultations in the COVID-19 era: the rates of conversion to face-to-face appointments and discharges in the post-pandemic years

Adlan Wafi Ramli - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Clinical triage: Investing in the front door

Elizabeth MacPhie - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Early inflammatory arthritis

N/A

Clinical triage and targeting education to improve quality of referrals

Elizabeth MacPhie - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved